Area of Research: Genetic Markers
2016 Grant Recipients
- Pradeep Chaluvally-Raghavan, PhD, Medical College of Wisconsin Early Career Investigator GrantUnexpected Role of CLDN11 cdRNA in Ovarian Cancer
2015 Grant Recipients
- Michael Yaffe, MD, PhD, Massachusetts Institute of Technology Collaborative Research Development GrantUsing Functional Genetics and Nanomedicine for Ovarian Cancer Treatments
- Nicole Spardy, PhD, Dana Farber Cancer Institute Mentored Investigator GrantIdentification of New Genetic Dependencies in HR-deficient Ovarian Cancers
- Daniela Dinulescu, PhD, Brigham and Women’s Hospital Early Career Investigator GrantModeling Serous Ovarian Carcinoma Using Genetic Markers Specific for the Distal Fallopian Tube
2014 Grant Recipients
- Rachel Grisham, MD, Memorial Sloan Kettering Cancer Center Early Career Investigator GrantDetermining the Molecular Drivers of Low-Grade Serous Ovarian Cancer
- Barbara Stulken Norquist, MD, University of Washington Early Career Investigator GrantMolecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
- Ellen Cheon, PhD, Cedars-Sinai Medical Center Mentored Investigator GrantCollagen-Remodeling Genes Provide a Niche for Ovarian Cancer
2013 Grant Recipients
- Simon Gayther, PhD, University of Southern California Collaborative Research Development GrantFunctional Analysis of Genetic Susceptibility Loci to Identify Biomarkers and Candidate Genes Associated with Ovarian Cancer Initiation, Progression and Outcome
- Pradeep Chaluvally-Raghavan, PhD, MD Anderson Cancer Center Mentored Investigator GrantRole of microRNAs in the 3q26 Amplicon in Ovarian Cancer Pathophysiology and Therapy
- David Pepin, PhD, Massachusetts General Hospital Mentored Investigator GrantMechanisms and Markers to Target a Stem Enriched Population of Primary Ovarian Cancer Ascites with the Müllerian Inhibiting Substance
2012 Grant Recipients
- Bin Guan, PhD, Johns Hopkins University School of Medicine Mentored Investigator GrantFunctional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
- Kate Lawrenson, PhD, University of Southern California Mentored Investigator GrantModeling Stem Cell Origins of Epithelial Ovarian Carcinomas
- Daniela Dinulescu, PhD, Brigham and Women’s Hospital Early Career Investigator GrantModeling Serous Ovarian Carcinoma Using Genetic Markers Specific for the Distal Fallopian Tube
- See-Hyoung Park, PhD, Stanford University Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
- Sharmistha Sarkar, PhD, MD Anderson Cancer Center Mentored Investigator GrantFinding a Marker to Detect Early Stage Ovarian Cancer
2009 Grant Recipients
- Andrew Berchuck, MD, Duke University Medical Center Collaborative Research Development GrantInternational Ovarian Cancer Association Consortium: Finding Genetic Markers of Ovarian Cancer Using Polymorphisms
2008 Grant Recipients
- Takayo Ota, MD, PhD, Mayo Clinic Rochester Mentored Investigator GrantCharacterizing the Genetic Alterations of Aggressive Ovarian Cancer
2007 Grant Recipients
- John Risinger, PhD, Michigan State University Individual Investigator AwardUnderstanding the Genetics of Metastasis May Help Prevent and Stop It
2006 Grant Recipients
- Ramandeep Rattan, PhD, Mayo Clinic Mentored Investigator GrantGene May Be an Early Marker for Ovarian Cancer
- Andres Matoso, MD, Cornell University Mentored Investigator GrantAn Animal Model to Study Major Genetic Alterations in Ovarian Cancer
- Maria Barbolina, PhD, University of Illinois - Chicago Mentored Investigator GrantEpigenetic Regulation of Metastasis-Associated Gene Expression in EOC
2005 Grant Recipients
- Andrew Berchuck, MD, Duke University Medical Center Collaborative Research Development GrantInternational Ovarian Cancer Association Consortium
2004 Grant Recipients
- Xiaoyan Ni, PhD, Brigham and Women’s Hospital Mentored Investigator GrantBiomarkers for Ovarian Cancer
2003 Grant Recipients
- Changping Zou, MD, PhD, University of Arizona Individual Investigator AwardFinding Biomarkers for Early Detection of Ovarian Cancer
- Monique Spillman, MD, PhD, Duke University Medical Center Mentored Investigator GrantRole of MAP2K4 Suppressing Metastasis of Serous Ovarian Cancers
- Kuan-Chun Huang, PhD, Brigham and Women’s Hospital Mentored Investigator GrantA Possible New Marker for Drug Resistance of Ovarian Cancer
2002 Grant Recipients
- Andrew K. Godwin, PhD, Fox Chase Cancer Center Individual Investigator AwardIdentification of Novel Genetic Markers of Response to Imatinib Mesylate in Ovarian Carcinomas
- Fergus Couch, PhD, Mayo Clinic Individual Investigator AwardFinding Genes Associated with Drug Resistance in Ovarian Cancer
2001 Grant Recipients
- Jingwei Yu, PhD, Eleanor Roosevelt Institute Individual Investigator AwardDevelopment of DNA Methylation Based Ovarian Cancer Specific Molecular Markers
2000 Grant Recipients
- Iman Osman, MD, University of New Mexico Individual Investigator AwardHypoxia Inducible Factor-1 alpha (HIF-1): A Potential New Prognostic Marker for Advanced Ovarian Cancer and Target of Treatment